MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
9.13
+0.56 (6.60%)
At close: Mar 25, 2026, 4:00 PM EDT
9.11
-0.02 (-0.16%)
After-hours: Mar 25, 2026, 7:15 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $42.83 million as of March 25, 2026. Its market cap has increased by 41.10% in one year.
Market Cap
42.83M
Enterprise Value
34.28M
1-Year Change
41.10%
Ranking
Category
Stock Price
$9.13
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $42.83M, a decrease of -88.91%. That is a compound annual growth rate of -39.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 40.18M | -23.23% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 46.33M |
| Lisata Therapeutics | 45.30M |
| GeoVax Labs | 45.09M |
| Telomir Pharmaceuticals | 44.01M |
| Aligos Therapeutics | 43.96M |
| Lite Strategy | 43.27M |
| Plus Therapeutics | 42.65M |
| Sensei Biotherapeutics | 42.44M |